TESTBANK
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy-L. Wright
, TABLE OF CONTENTWW WW
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber.......................................................................4
WW WW WW WW WW WW WW WW WW WW
Chapter 2. Review of Basic Principles of Pharmacology ......................................................................................5
WW WW WW WW WW WW WW
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
WW WW WW WW
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
WW WW WW WW WW WW WW
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
WW WW WW WW
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
WW WW WW WW WW
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
WW WW WW WW
Chapter 8. Herbal Therapies ................................................................................................................................ 28
WW WW WW
Chapter 9. Cannabis ............................................................................................................................................ 31
WW WW
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
WW WW
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
WW WW WW WW WW WW WW
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
WW WW WW WW WW WW WW
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
WW WW WW WW WW WW WW WW
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
WW WW WW WW WW WW
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
WW WW WW WW WW WW
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
WW WW WW WW WW WW WW WW WW
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
WW WW WW WW WW WW WW
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
WW WW WW WW WW WW
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
W
W WW WW WW WW WW WW WW WW WW WW
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
WW WW WW WW WW WW WW WW WW WW WW
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
WW WW WW WW WW WW
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
WW WW WW WW WW WW WW
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
WW WW WW WW WW WW
Chapter 24. Drugs Used to Treat Bacterial Infections........................................................................................101
WW WW WW WW WW WW WW
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................105
WW WW WW WW WW WW WW WW WW WW
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................108
WW WW WW WW WW WW WW
Chapter 27. Drugs Used to Treat Eye and Ear-Disorders ...................................................................................111
WW WW WW WW WW WW WW WW
Chapter 28. Anemia............................................................................................................................................113
WW WW
Chapter 29. Anxiety and Depression..................................................................................................................116
WW WW WW WW
Chapter 30. Attention Deficit-Hyperactivity-Disorder .......................................................................................120
WW WW WW
Chapter 31. Asthma and Allergy ........................................................................................................................122
WW WW WW WW
Chapter 32. Chronic Obstructive Pulmonary-Disease ........................................................................................125
WW WW WW WW
Chapter 33. Contraception ..................................................................................................................................127
WW WW
Chapter 34. COVID-19: Acute and Chronic ......................................................................................................130
WW WW WW WW WW
Chapter 35. Dermatological Conditions .............................................................................................................134
WW WW WW
Chapter 36. Diabetes Management.....................................................................................................................138
WW WW WW
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer-Disease .......................................................................146
WW WW WW WW WW WW
Chapter 38. Headaches .......................................................................................................................................149
WW WW
Chapter 39. Heart Failure ...................................................................................................................................153
WW WW WW
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................158
WW WW WW WW WW WW WW
Chapter 41. Menopausal Hormone Therapy ......................................................................................................161
WW WW WW WW
,Chapter 42. Hyperlipidemia ...............................................................................................................................164
WW WW
Chapter 43. Hypertension ...................................................................................................................................169
WW WW
Chapter 44. Hyperthyroidism and Hypothyroidism ...........................................................................................174
WW WW WW WW
Chapter 45. Obesity ............................................................................................................................................177
WW WW
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................181
WW WW WW WW WW WW WW
Chapter 47. Pneumonia ......................................................................................................................................185
WW WW
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................187
WW WW WW WW WW WW
Chapter 49. Substance Use Disorders ................................................................................................................190
WW WW WW WW
Chapter 50. Tuberculosis ....................................................................................................................................195
WW WW
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ...........197
W
W WW WW WW WW WW WW WW W
W WW WW WW
Chapter 52. Urinary Tract Infections .................................................................................................................200
WW WW WW WW
Chapter 53. Women as Patients..........................................................................................................................203
WW WW WW WW
Chapter 54. Men as Patients ...............................................................................................................................207
WW WW WW WW
Chapter 55. Pediatric Patients.............................................................................................................................209
WW WW WW
Chapter 57. Geriatric Patients.............................................................................................................................213
WW WW WW
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 WW WW WW WW Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
WW WW WW WW WW WW WW WW WW WW
MULTIPLE CHOICE WW
1. Nurse practitioner-prescriptive authority is regulated by:
WW WW WW WW WW
A. The National Council of State Boards of Nursing
WW WW WW WW WW WW WW
B. The U.S. Drug Enforcement Administration
WW WW WW WW
C. The State Board of Nursing for each state
WW WW WW WW WW WW WW
D. The State Board of Pharmacy
WW WW WW WW
ANS: C W W PTS: W W W W 1
2. The-benefits to the patient of having an advanced practice-
WW WW WW WW WW WW WW WW
registered nurse (APRN) prescriber include:
WW WW WW WW
A. Nurses know- WW
more about pharmacology than other prescribers because they take it both in their
WW WW WW WW WW WW WW WW WW WW WW WW
basic nursing program and in their APRN program.
WW WW WW WW WW WW WW WW
B. Nurses care for the patient from a holistic approach and include the patient in
WW WW WW WW WW WW WW WW WW WW WW WW WW W
decision-making regarding their care.
W WW WW WW
C. APRNs are less likely-to prescribe narcotics and other-controlled substances.
WW WW WW WW WW WW WW W
W
D. APRNs are able to prescribe- WW WW WW WW
independently in all states, whereas a physician’s assistant needs to have a p
WW WW WW WW WW WW WW WW WW WW WW WW
hysician supervising their practice. WW WW WW
ANS: B W W PTS: W W W W 1
3. Clinical judgment in prescribing includes:
WW WW WW WW
A. Factoring in the cost to the patient of the medication prescribed
WW WW WW WW WW WW WW WW WW WW
B. Always prescribing the newest medication available for the disease process
WW WW WW WW WW WW WW WW W
W
C. Handing-out drug samples to poor patients WW WW WW WW WW
D. Prescribing all generic medications to cut costs WW WW WW WW WW WW
ANS: A W W PTS: W W W W 1
4. The process for choosing an effective drug for a disorder-includes:
WW WW WW WW WW WW WW WW WW
A. Asking the patient what drug they think would work best for-them
WW WW WW WW WW WW WW WW WW WW
B. Consulting nationally-recognized guidelines for disease management
WW WW WW WW W
W
C. Prescribing medications that are available as samples before writing a prescription
WW WW WW WW WW WW WW WW WW WW
D. Following-U.S. Drug-Enforcement Administration guidelines for prescribing WW WW WW WW W
W
ANS: B W W PTS: W W W W 1
5. Nonintentional nonadherence of drug therapy may occur-due to:
WW WW WW WW WW WW WW
A. Belief-that medication does not work WW WW WW WW
B. Adverse drug reactions WW WW
C. Chronic conditions that require daily therapy
WW WW WW WW WW
D. Forgetfulness or distraction WW W
W
ANS: D W W PTS: W W W W 1
Pharmacotherapeutics for Advanced Practice Nurse Prescribers, 6th Edition
Author: Teri Moser Woo and Wendy-L. Wright
, TABLE OF CONTENTWW WW
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber.......................................................................4
WW WW WW WW WW WW WW WW WW WW
Chapter 2. Review of Basic Principles of Pharmacology ......................................................................................5
WW WW WW WW WW WW WW
Chapter 3. Rational Drug Selection ..................................................................................................................... 11
WW WW WW WW
Chapter 4. Legal and Professional Issues in Prescribing ..................................................................................... 14
WW WW WW WW WW WW WW
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
WW WW WW WW
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
WW WW WW WW WW
Chapter 7. Nutrition and Nutraceuticals .............................................................................................................. 22
WW WW WW WW
Chapter 8. Herbal Therapies ................................................................................................................................ 28
WW WW WW
Chapter 9. Cannabis ............................................................................................................................................ 31
WW WW
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
WW WW
Chapter 11. Drugs Affecting the Autonomic Nervous System ........................................................................... 38
WW WW WW WW WW WW WW
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................. 45
WW WW WW WW WW WW WW
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................. 53
WW WW WW WW WW WW WW WW
Chapter 14. Drugs Affecting the Respiratory System ......................................................................................... 61
WW WW WW WW WW WW
Chapter 15. Drugs Affecting the Hematological System .................................................................................... 65
WW WW WW WW WW WW
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
WW WW WW WW WW WW WW WW WW
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
WW WW WW WW WW WW WW
Chapter 18. Drugs Affecting the Gastrointestinal System .................................................................................. 77
WW WW WW WW WW WW
Chapter 19. Drugs Affecting the Endocrine System: Pancreatic Hormones and Antidiabetic Drugs ................... 80
W
W WW WW WW WW WW WW WW WW WW WW
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs ............................ 83
WW WW WW WW WW WW WW WW WW WW WW
Chapter 21. Drugs Affecting the Reproductive System ...................................................................................... 86
WW WW WW WW WW WW
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................. 92
WW WW WW WW WW WW WW
Chapter 23. Drugs Affecting the Integumentary System .................................................................................... 96
WW WW WW WW WW WW
Chapter 24. Drugs Used to Treat Bacterial Infections........................................................................................101
WW WW WW WW WW WW WW
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections ........................................................105
WW WW WW WW WW WW WW WW WW WW
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................108
WW WW WW WW WW WW WW
Chapter 27. Drugs Used to Treat Eye and Ear-Disorders ...................................................................................111
WW WW WW WW WW WW WW WW
Chapter 28. Anemia............................................................................................................................................113
WW WW
Chapter 29. Anxiety and Depression..................................................................................................................116
WW WW WW WW
Chapter 30. Attention Deficit-Hyperactivity-Disorder .......................................................................................120
WW WW WW
Chapter 31. Asthma and Allergy ........................................................................................................................122
WW WW WW WW
Chapter 32. Chronic Obstructive Pulmonary-Disease ........................................................................................125
WW WW WW WW
Chapter 33. Contraception ..................................................................................................................................127
WW WW
Chapter 34. COVID-19: Acute and Chronic ......................................................................................................130
WW WW WW WW WW
Chapter 35. Dermatological Conditions .............................................................................................................134
WW WW WW
Chapter 36. Diabetes Management.....................................................................................................................138
WW WW WW
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer-Disease .......................................................................146
WW WW WW WW WW WW
Chapter 38. Headaches .......................................................................................................................................149
WW WW
Chapter 39. Heart Failure ...................................................................................................................................153
WW WW WW
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome .............................................................158
WW WW WW WW WW WW WW
Chapter 41. Menopausal Hormone Therapy ......................................................................................................161
WW WW WW WW
,Chapter 42. Hyperlipidemia ...............................................................................................................................164
WW WW
Chapter 43. Hypertension ...................................................................................................................................169
WW WW
Chapter 44. Hyperthyroidism and Hypothyroidism ...........................................................................................174
WW WW WW WW
Chapter 45. Obesity ............................................................................................................................................177
WW WW
Chapter 46. Pain Management: Acute and Chronic Pain ...................................................................................181
WW WW WW WW WW WW WW
Chapter 47. Pneumonia ......................................................................................................................................185
WW WW
Chapter 48. Sexually Transmitted Diseases and Vaginitis .................................................................................187
WW WW WW WW WW WW
Chapter 49. Substance Use Disorders ................................................................................................................190
WW WW WW WW
Chapter 50. Tuberculosis ....................................................................................................................................195
WW WW
Chapter 51. Upper Respiratory Tract Infection, Pharyngitis, Sinusitis, Otitis Media, and Otitis Externa ...........197
W
W WW WW WW WW WW WW WW W
W WW WW WW
Chapter 52. Urinary Tract Infections .................................................................................................................200
WW WW WW WW
Chapter 53. Women as Patients..........................................................................................................................203
WW WW WW WW
Chapter 54. Men as Patients ...............................................................................................................................207
WW WW WW WW
Chapter 55. Pediatric Patients.............................................................................................................................209
WW WW WW
Chapter 57. Geriatric Patients.............................................................................................................................213
WW WW WW
, Woo 1
Pharmacotherapeutics for APN Prescribers, 6 WW WW WW WW Ch01
e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
WW WW WW WW WW WW WW WW WW WW
MULTIPLE CHOICE WW
1. Nurse practitioner-prescriptive authority is regulated by:
WW WW WW WW WW
A. The National Council of State Boards of Nursing
WW WW WW WW WW WW WW
B. The U.S. Drug Enforcement Administration
WW WW WW WW
C. The State Board of Nursing for each state
WW WW WW WW WW WW WW
D. The State Board of Pharmacy
WW WW WW WW
ANS: C W W PTS: W W W W 1
2. The-benefits to the patient of having an advanced practice-
WW WW WW WW WW WW WW WW
registered nurse (APRN) prescriber include:
WW WW WW WW
A. Nurses know- WW
more about pharmacology than other prescribers because they take it both in their
WW WW WW WW WW WW WW WW WW WW WW WW
basic nursing program and in their APRN program.
WW WW WW WW WW WW WW WW
B. Nurses care for the patient from a holistic approach and include the patient in
WW WW WW WW WW WW WW WW WW WW WW WW WW W
decision-making regarding their care.
W WW WW WW
C. APRNs are less likely-to prescribe narcotics and other-controlled substances.
WW WW WW WW WW WW WW W
W
D. APRNs are able to prescribe- WW WW WW WW
independently in all states, whereas a physician’s assistant needs to have a p
WW WW WW WW WW WW WW WW WW WW WW WW
hysician supervising their practice. WW WW WW
ANS: B W W PTS: W W W W 1
3. Clinical judgment in prescribing includes:
WW WW WW WW
A. Factoring in the cost to the patient of the medication prescribed
WW WW WW WW WW WW WW WW WW WW
B. Always prescribing the newest medication available for the disease process
WW WW WW WW WW WW WW WW W
W
C. Handing-out drug samples to poor patients WW WW WW WW WW
D. Prescribing all generic medications to cut costs WW WW WW WW WW WW
ANS: A W W PTS: W W W W 1
4. The process for choosing an effective drug for a disorder-includes:
WW WW WW WW WW WW WW WW WW
A. Asking the patient what drug they think would work best for-them
WW WW WW WW WW WW WW WW WW WW
B. Consulting nationally-recognized guidelines for disease management
WW WW WW WW W
W
C. Prescribing medications that are available as samples before writing a prescription
WW WW WW WW WW WW WW WW WW WW
D. Following-U.S. Drug-Enforcement Administration guidelines for prescribing WW WW WW WW W
W
ANS: B W W PTS: W W W W 1
5. Nonintentional nonadherence of drug therapy may occur-due to:
WW WW WW WW WW WW WW
A. Belief-that medication does not work WW WW WW WW
B. Adverse drug reactions WW WW
C. Chronic conditions that require daily therapy
WW WW WW WW WW
D. Forgetfulness or distraction WW W
W
ANS: D W W PTS: W W W W 1
